Sotigalimab, CAS 2305607-45-6

Product Description: Sotigalimab, a CD40 agonistic monoclonal antibody, can be used for the research of metastatic pancreatic adenocarcinoma[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Mark H O'Hara, et al. CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study. Lancet Oncol. 2021 Jan;22(1)

CAS Number: 2305607-45-6

Molecular Weight: N/A

Compound Purity: 98.90

Research Area: Cancer; Inflammation/Immunology

Solubility: H2O

Target: Others

• SKU: MEXHY-P99049-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99049-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK